中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2013年
37期
2976-2978
,共3页
务森%陈明耀%雒建超%魏立%陈重
務森%陳明耀%雒建超%魏立%陳重
무삼%진명요%락건초%위립%진중
食管肿瘤%药物疗法,联合%挽救疗法
食管腫瘤%藥物療法,聯閤%輓救療法
식관종류%약물요법,연합%만구요법
Esophageal neoplasms%Drug therapy,combination%Salvage therapy
目的 研究根治性放化疗局部未控或复发后进行挽救性手术的安全性和疗效.方法 采用回顾性调查方法,收集河南省人民医院2008年7月至2010年6月根治性放化疗局部失败后进行挽救性手术和非手术治疗的cT1-3 N0-1M0病例共37例,观察手术成功率、并发症发生率和近期生存率.结果 26例进行了挽救性手术,11例给予化疗等非手术治疗.挽救性手术切除率84.6%(22/26),完全性切除率69.2%(18/26).无围手术期死亡病例.并发症发生率为53.8%(14/26),其中肺部感染8例(30.8%),吻合口瘘3例(11.5%),心率失常2例(7.7%),喉返神经损伤l例(3.8%).中位生存期11.1个月,2年生存率23.1%.非手术治疗组中位生存期8.1(3.1~15.1)个月.挽救性手术组生存期长于非手术治疗组(Kaplan-Meier方法,x2=6.14,P=0.013).结论 根治性放化疗后局部未控或复发的病例,挽救性手术较非手术治疗可以有效延长生存期,鉴于术后并发症发生率较高,术前应严格评估身体状态和病变的完全性切除可能性.
目的 研究根治性放化療跼部未控或複髮後進行輓救性手術的安全性和療效.方法 採用迴顧性調查方法,收集河南省人民醫院2008年7月至2010年6月根治性放化療跼部失敗後進行輓救性手術和非手術治療的cT1-3 N0-1M0病例共37例,觀察手術成功率、併髮癥髮生率和近期生存率.結果 26例進行瞭輓救性手術,11例給予化療等非手術治療.輓救性手術切除率84.6%(22/26),完全性切除率69.2%(18/26).無圍手術期死亡病例.併髮癥髮生率為53.8%(14/26),其中肺部感染8例(30.8%),吻閤口瘺3例(11.5%),心率失常2例(7.7%),喉返神經損傷l例(3.8%).中位生存期11.1箇月,2年生存率23.1%.非手術治療組中位生存期8.1(3.1~15.1)箇月.輓救性手術組生存期長于非手術治療組(Kaplan-Meier方法,x2=6.14,P=0.013).結論 根治性放化療後跼部未控或複髮的病例,輓救性手術較非手術治療可以有效延長生存期,鑒于術後併髮癥髮生率較高,術前應嚴格評估身體狀態和病變的完全性切除可能性.
목적 연구근치성방화료국부미공혹복발후진행만구성수술적안전성화료효.방법 채용회고성조사방법,수집하남성인민의원2008년7월지2010년6월근치성방화료국부실패후진행만구성수술화비수술치료적cT1-3 N0-1M0병례공37례,관찰수술성공솔、병발증발생솔화근기생존솔.결과 26례진행료만구성수술,11례급여화료등비수술치료.만구성수술절제솔84.6%(22/26),완전성절제솔69.2%(18/26).무위수술기사망병례.병발증발생솔위53.8%(14/26),기중폐부감염8례(30.8%),문합구루3례(11.5%),심솔실상2례(7.7%),후반신경손상l례(3.8%).중위생존기11.1개월,2년생존솔23.1%.비수술치료조중위생존기8.1(3.1~15.1)개월.만구성수술조생존기장우비수술치료조(Kaplan-Meier방법,x2=6.14,P=0.013).결론 근치성방화료후국부미공혹복발적병례,만구성수술교비수술치료가이유효연장생존기,감우술후병발증발생솔교고,술전응엄격평고신체상태화병변적완전성절제가능성.
Objective To evaluate the feasibility and efficacy of salvage surgery after local failure of definitive chemoradiotherapy (dCRT) for esophageal carcinomas.Methods We retrospectively reviewed the esophageal cancer patients underwent salvage surgery (Group A,26 cases) or non-surgical therapy (Group B,11 cases) after local failure of dCRT(cT1-3 N0 1 M0) between July 2008 and June 2010.Results The rate of resection was 84.6% in Group A,R0 was 69.2%.There was no mortality after surgery.The rate of postoperative complications is 53.8%,especially pneumonia 30.8%,anastomosis leakage11.5% and arrhythmia 7.7%.The median survival time is 11.1 months; the 2-year survival rate of Group A was 23.1% in Group A.The non-surgical therapy was given including second-line chemotherapy and esophagus stents;the median survival time is 8.1 months (3.1-15.1) in Group B.The survival rate of Group A was higher than Group B (Kaplan-Meier,P =0.013).Conclusion Salvage surgery provides survival benefit for esophageal cancer patients with local persistent or recurrence after primary dCRT,despite of high morbidity.Salvage surgery should be carried out for patients with good physical condition and complete resection is technically possible.